CN110736829A - Rapid detection of T-2 toxin in food based on nucleic acid hydrogel - Google Patents
Rapid detection of T-2 toxin in food based on nucleic acid hydrogel Download PDFInfo
- Publication number
- CN110736829A CN110736829A CN201910919297.4A CN201910919297A CN110736829A CN 110736829 A CN110736829 A CN 110736829A CN 201910919297 A CN201910919297 A CN 201910919297A CN 110736829 A CN110736829 A CN 110736829A
- Authority
- CN
- China
- Prior art keywords
- toxin
- nucleic acid
- acid hydrogel
- solution
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 81
- BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 title claims abstract description 68
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 43
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 43
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 43
- 235000013305 food Nutrition 0.000 title claims abstract description 24
- 238000001514 detection method Methods 0.000 title claims abstract description 21
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 51
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 51
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 30
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 28
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 26
- 238000010521 absorption reaction Methods 0.000 claims abstract description 21
- 108091023037 Aptamer Proteins 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 15
- 239000000499 gel Substances 0.000 claims abstract description 11
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 6
- 239000011630 iodine Substances 0.000 claims abstract description 6
- 230000000295 complement effect Effects 0.000 claims description 54
- 239000000243 solution Substances 0.000 claims description 54
- 239000006228 supernatant Substances 0.000 claims description 18
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 8
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 238000005530 etching Methods 0.000 claims description 6
- 238000002211 ultraviolet spectrum Methods 0.000 claims description 5
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 4
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- XBECFEJUQZXMFE-UHFFFAOYSA-N n-(4-aminobutyl)acetamide;hydrochloride Chemical compound Cl.CC(=O)NCCCCN XBECFEJUQZXMFE-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 239000008055 phosphate buffer solution Substances 0.000 claims 1
- 238000005086 pumping Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 239000003053 toxin Substances 0.000 description 13
- 231100000765 toxin Toxicity 0.000 description 13
- 108700012359 toxins Proteins 0.000 description 13
- 238000005457 optimization Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000003917 TEM image Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 231100000678 Mycotoxin Toxicity 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002636 mycotoxin Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000008366 buffered solution Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002115 aflatoxin B1 Substances 0.000 description 2
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 2
- 229930020125 aflatoxin-B1 Natural products 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 229930013292 trichothecene Natural products 0.000 description 2
- 150000003327 trichothecene derivatives Chemical class 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000005102 Kashin-Beck Disease Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003008 fumonisin Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930183344 ochratoxin Natural products 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及食品检测技术领域,具体涉及一种基于核酸水凝胶快速检测食品中T-2毒素的方法。The invention relates to the technical field of food detection, in particular to a method for rapidly detecting T-2 toxin in food based on nucleic acid hydrogel.
背景技术Background technique
本发明对于背景技术的描述属于与本发明相关的相关技术,仅仅是用于说明和便于理解本发明的发明内容,不应理解为申请人明确认为或推定申请人认为是本发明在首次提出申请的申请日的现有技术。The description of the background technology in the present invention belongs to the related art related to the present invention, and is only used to illustrate and facilitate the understanding of the invention content of the present invention, and should not be construed as the applicant's explicit belief or presumption that the applicant believes that the present invention is the first application of the present invention. the prior art of the filing date.
近年来,有关真菌毒素残留的食品安全问题层出不穷,常见的有单端孢霉毒素类、黄曲霉毒素、玉米赤霉烯酮等,其中T-2毒素是单端孢霉A型毒素中最主要、也是毒性最强的一种。T-2毒素主要作用于细胞分裂旺盛的组织器官,能抑制DNA、RNA及蛋白质的合成,具有较强的基因毒性、免疫毒性、血液毒性,致癌致畸,有致死作用,对皮肤细胞以及遗传也具有毒性,还能诱导细胞凋亡。T-2毒素的纯品为白色针状结晶,分子式为C24H34O9,分子量为466.51,性质稳定,有很强的耐热性和紫外线耐受性,在室温条件下相当稳定,放置6~7年或加热至100~120℃1h毒性不减,因此在食物生产和加工过程中高压灭菌不易灭活。有研究表明T-2毒素可能与人类食物中毒性白细胞缺乏病症、大骨节病和克山病有着密切的关系。In recent years, food safety issues related to mycotoxins have emerged in an endless stream. The common ones include trichothecenes, aflatoxins, zearalenone, etc. Among them, T-2 toxin is the most important type of trichothecenes A toxin. , is also the most toxic one. T-2 toxin mainly acts on tissues and organs with vigorous cell division. It can inhibit the synthesis of DNA, RNA and protein. It has strong genotoxicity, immunotoxicity, blood toxicity, carcinogenicity, teratogenicity, and lethal effect. It is also toxic and induces apoptosis. The pure product of T-2 toxin is a white needle-like crystal, the molecular formula is C 24 H 34 O 9 , the molecular weight is 466.51, the property is stable, and it has strong heat resistance and ultraviolet resistance. It is quite stable at room temperature. 6 to 7 years or heated to 100 to 120 ℃ for 1 hour, the toxicity is not reduced, so it is not easy to be inactivated by autoclaving during food production and processing. Studies have shown that T-2 toxin may be closely related to human food-induced toxic leukocytosis, Kashin-Beck disease and Keshan disease.
目前,许多分析技术已被用于T-2毒素检测,包括薄层层析法(Thin-layerChromatography,TLC)、高效液相色谱(High Performance Liquid Chromatography,HPLC)、气相质谱联用技术(Gas Chromatography-Mass Spectrometry,GC-MS)和酶联免疫法(Enzyme-Linked Immunosorbent Assay,ELISA)等,这些高灵敏度和高选择性的方法是T-2毒素定量分析最常用的方法。此外,基于抗原抗体特异性识别的免疫学分析方法也为T-2毒素定量快速检测方法的建立提供了技术支持。但这些方法仪器设备昂贵,检测费用高,要求样品经过严格的预处理,检测时间较长。At present, many analytical techniques have been used for the detection of T-2 toxin, including Thin-layer Chromatography (TLC), High Performance Liquid Chromatography (HPLC), Gas Chromatography (Gas Chromatography) -Mass Spectrometry, GC-MS) and enzyme-linked immunosorbent assay (Enzyme-Linked Immunosorbent Assay, ELISA), these high sensitivity and high selectivity methods are the most commonly used methods for quantitative analysis of T-2 toxin. In addition, the immunological analysis method based on the specific recognition of antigen and antibody also provided technical support for the establishment of a quantitative and rapid detection method for T-2 toxin. However, these methods have expensive equipment and high detection costs, require samples to undergo strict pretreatment, and have a long detection time.
发明内容SUMMARY OF THE INVENTION
本发明实施例的目的是提供一种基于核酸水凝胶快速检测食品中T-2毒素的方法,本发明方法本发明方法简单、快捷、快速,具有良好的选择性和灵敏度,可用于食品安全检测中实际样品的分析。The purpose of the embodiments of the present invention is to provide a method for rapid detection of T-2 toxin in food based on nucleic acid hydrogel. The method of the present invention The method of the present invention is simple, fast, fast, has good selectivity and sensitivity, and can be used for food safety. Analysis of actual samples in testing.
本发明实施例提供了一种基于核酸水凝胶快速检测食品中T-2毒素的方法,包括如下步骤:The embodiment of the present invention provides a method for rapidly detecting T-2 toxin in food based on nucleic acid hydrogel, comprising the following steps:
构建以T-2毒素适体为linker交联剂的核酸水凝胶,所述的核酸水凝胶中均匀包埋着辣根过氧化物酶;Constructing a nucleic acid hydrogel using T-2 toxin aptamer as a linker cross-linking agent, wherein horseradish peroxidase is evenly embedded in the nucleic acid hydrogel;
向所述的核酸水凝胶中加入加入待测样,待测样中T-2毒素浓度为0.01ng mL-1-10000ng mL-1,所述的T-2毒素适体与T-2毒素结合,凝胶破裂,释放出辣根过氧化物酶;A sample to be tested is added to the nucleic acid hydrogel, the concentration of T-2 toxin in the sample to be tested is 0.01ng mL -1 -10000ng mL -1 , the T-2 toxin aptamer and T-2 toxin bind, the gel breaks, releasing horseradish peroxidase;
在一定时间内,辣根过氧化物酶催化过氧化氢和碘化钾反应生成碘单质刻蚀金纳米棒,根据金纳米棒在紫外分光光度计下呈现的吸收峰计算T-2毒素的含量。In a certain period of time, horseradish peroxidase catalyzes the reaction of hydrogen peroxide and potassium iodide to generate iodine to etch gold nanorods, and the content of T-2 toxin is calculated according to the absorption peak of gold nanorods under UV spectrophotometer.
进一步的,所述的构建以T-2毒素适体为交联剂的核酸水凝胶包括如下步骤:Further, the described construction of nucleic acid hydrogel using T-2 toxin aptamer as a cross-linking agent comprises the following steps:
修饰有丙烯酰胺的互补链A100μM和互补链B100μM分别加入终浓度为4wt%丙烯酰胺,随后在35-40℃抽排空气10-15min,除去氧气;100 μM of the complementary chain A and 100 μM of the complementary chain B modified with acrylamide were respectively added with a final concentration of 4wt% acrylamide, and then the air was evacuated at 35-40 ° C for 10-15 min to remove oxygen;
加入终浓度为1.4%新鲜配制的过硫酸铵和终浓度为2.8%新鲜配制的四甲基乙二胺;在35-40℃抽排空气,反应10-15min,可得到髙分子互补链A和互补链B;Add freshly prepared ammonium persulfate with a final concentration of 1.4% and freshly prepared tetramethylethylenediamine with a final concentration of 2.8%; extract the air at 35-40°C, and react for 10-15min to obtain high molecular complementary chains A and complementary strand B;
将髙分子互补链A和互补链B混匀后在60-65℃下孵育5-10min,重复加热两次确保试剂完全混匀。随后加入不同浓度的交联剂(30、35、40、45μM)及辣根过氧化物酶,在60-65℃下孵育5-10min,重复加热3次确保试剂混匀,再冷却至室温形成核酸水凝胶。Mix the high molecular complementary strand A and the complementary strand B, incubate at 60-65 °C for 5-10 min, and repeat the heating twice to ensure that the reagents are completely mixed. Then add different concentrations of cross-linking agent (30, 35, 40, 45 μM) and horseradish peroxidase, incubate at 60-65 °C for 5-10 min, repeat heating 3 times to ensure that the reagents are mixed, and then cool to room temperature to form Nucleic acid hydrogels.
用磷酸缓冲溶液洗涤胶平面,除去胶表面多余的辣根过氧化物酶。Wash the surface of the gel with phosphate buffered solution to remove excess horseradish peroxidase on the surface of the gel.
进一步的,所述的金纳米棒由如下方法制备而得:Further, the gold nanorods are prepared by the following method:
制备金种子:在0.5-1.0mL 0.5mM四氯金酸溶液中加入0.5-1.0mL 0.2M十六烷基三甲基溴化铵溶液;振荡混匀后,立即加入0.1-0.2mL 6mM新鲜配制的硼氢化钠溶液;剧烈振荡2-5min,种子溶液由黄色变成茶色,室温静置30-45min后即可得到金种子,常温保存,备用;To prepare gold seeds: add 0.5-1.0mL of 0.2M cetyltrimethylammonium bromide solution to 0.5-1.0mL of 0.5mM tetrachloroauric acid solution; after shaking and mixing, immediately add 0.1-0.2mL of 6mM freshly prepared The sodium borohydride solution; Vigorously shake for 2-5min, the seed solution changes from yellow to brown, and then stand at room temperature for 30-45min to obtain gold seeds, store at room temperature for later use;
制备生长液:称取0.9-1.1g十六烷基三甲基溴化铵及0.11-0.13g 5-溴水杨酸于250mL圆底烧瓶中,用25-30mL温水(50-70℃)溶解;随后加入1.2-1.5mL 4.0mM硝酸银溶液。得到的溶液放入30-37℃的水浴锅中下静置15-20min后,加入25mL 1.0mM四氯金酸溶液,搅拌15-20min;最后加入0.2mL 0.064-0.072M抗坏血酸,混匀30-60s直至溶液变成无色,即可得到生长液;Preparation of growth solution: Weigh 0.9-1.1g cetyltrimethylammonium bromide and 0.11-0.13g 5-bromosalicylic acid in a 250mL round-bottom flask, dissolve with 25-30mL warm water (50-70℃) ; 1.2-1.5 mL of 4.0 mM silver nitrate solution was then added. The obtained solution was placed in a water bath at 30-37°C and allowed to stand for 15-20min, then 25mL of 1.0mM tetrachloroauric acid solution was added and stirred for 15-20min; finally, 0.2mL of 0.064-0.072M ascorbic acid was added and mixed for 30- 60s until the solution becomes colorless, the growth solution can be obtained;
金纳米棒的生长:在上述得到的生长液中加入80-85μL制得的种子液,混匀后置于30-37℃水浴锅中,静置12-14h,得到所需的金纳米棒。最后,得到的金纳米棒用0.05M十六烷基三甲基溴化铵离心重悬3遍除去生长液。Growth of gold nanorods: Add 80-85 μL of the obtained seed solution to the growth solution obtained above, mix well, place in a water bath at 30-37°C, and let stand for 12-14 hours to obtain the desired gold nanorods. Finally, the obtained gold nanorods were centrifuged and resuspended three times with 0.05M cetyltrimethylammonium bromide to remove the growth solution.
进一步的,所述的髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为110:100:45时,核酸水凝胶响应时间为15min。Further, when the substance ratio of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 110:100:45, the response time of the nucleic acid hydrogel is 15 minutes.
进一步的,所述的碘化钾的浓度为0.10M。Further, the concentration of the potassium iodide is 0.10M.
进一步的,所述的过氧化氢的浓度为0.075M。Further, the concentration of the hydrogen peroxide is 0.075M.
进一步的,根据金纳米棒在紫外分光光度计下呈现的吸收峰计算T-2毒素的含量包括步骤:建立标准曲线:在上述水凝胶中加入10μL不同浓度的T-2毒素标准样品,室温下静置15min后,移出上清液于2mL 0.05mg/mL金纳米棒,5mL 0.10M碘化钾20mL 0.075M过氧化氢中,室温下静置3min后,进行紫外光谱扫描。Further, calculating the content of T-2 toxin according to the absorption peak presented by the gold nanorods under the UV spectrophotometer includes the following steps: establishing a standard curve: adding 10 μL of T-2 toxin standard samples of different concentrations to the above hydrogel, at room temperature After standing at room temperature for 15 min, the supernatant was removed and placed in 2 mL of 0.05 mg/mL gold nanorods, 5 mL of 0.10 M potassium iodide, 20 mL of 0.075 M hydrogen peroxide, and after standing at room temperature for 3 min, ultraviolet spectrum scanning was performed.
本发明实施例具有如下有益效果:The embodiment of the present invention has the following beneficial effects:
本发明方法是基于金纳米棒和核酸水凝胶的食品中T-2毒素的快速检测方法。构建以T-2毒素适体为linker的核酸水凝胶,水凝胶中均匀包埋着辣根过氧化物酶(Horseradish Peroxidase,HRP)。毒素适体与毒素结合,凝胶破裂,释放出辣根过氧化物酶,在一定时间内,辣根过氧化物酶催化过氧化氢和碘化钾反应生成碘单质刻蚀金纳米棒,使金纳米棒呈现不同的颜色,并在紫外分光光度计下呈现不同位置的吸收峰。该发明方法检测T-2毒素的线性范围为0.01ng/mL~10000ng/mL,最低检测限为0.87pg mL-1。与现有技术相比,本发明方法简单、快捷、快速,具有良好的选择性和灵敏度,可用于食品安全检测中实际样品的分析。The method of the invention is a rapid detection method of T-2 toxin in food based on gold nanorods and nucleic acid hydrogel. A nucleic acid hydrogel with T-2 toxin aptamer as a linker was constructed, and Horseradish Peroxidase (HRP) was evenly embedded in the hydrogel. The toxin aptamer is combined with the toxin, the gel is broken, and horseradish peroxidase is released. Within a certain period of time, horseradish peroxidase catalyzes the reaction of hydrogen peroxide and potassium iodide to generate iodine and etch the gold nanorods, so that the gold nanorods are etched. The rods appear in different colors and show absorption peaks at different positions under the UV spectrophotometer. The inventive method has a linear range of 0.01 ng/mL to 10000 ng/mL for detecting T-2 toxin, and the lowest detection limit is 0.87 pg mL -1 . Compared with the prior art, the method of the present invention is simple, fast and rapid, has good selectivity and sensitivity, and can be used for the analysis of actual samples in food safety detection.
附图说明Description of drawings
图1为本发明基于核酸水凝胶快速检测食品中T-2毒素的流程示意图;Fig. 1 is the schematic flow chart of the present invention based on nucleic acid hydrogel rapid detection of T-2 toxin in food;
图2为金纳米棒刻蚀前TEM图;Figure 2 is a TEM image of gold nanorods before etching;
图3为金纳米棒刻蚀后TEM图;Figure 3 is a TEM image of gold nanorods after etching;
图4为刻蚀前后金纳米棒的紫外吸收光谱图;Fig. 4 is the ultraviolet absorption spectrogram of gold nanorods before and after etching;
图5为不可刻蚀性验证图;Figure 5 is a non-etchability verification diagram;
图6为水凝胶成胶条件的优化;Fig. 6 is the optimization of hydrogel gelation conditions;
图7为水凝胶水解时间的优化;Fig. 7 is the optimization of hydrogel hydrolysis time;
图8为碘化钾浓度的优化;Fig. 8 is the optimization of potassium iodide concentration;
图9为过氧化氢浓度的优化;Fig. 9 is the optimization of hydrogen peroxide concentration;
图10为未瓦解水凝胶TEM图;Figure 10 is a TEM image of the undisintegrated hydrogel;
图11为完全瓦解水凝胶TEM图;Figure 11 is a TEM image of a completely disintegrated hydrogel;
图12为基于核酸水凝胶快速检测食品中T-2毒素的紫外光谱图;Fig. 12 is the ultraviolet spectrum of rapid detection of T-2 toxin in food based on nucleic acid hydrogel;
图13为基于核酸水凝胶快速检测食品中T-2毒素的标准曲线图;Figure 13 is a standard curve diagram of rapid detection of T-2 toxin in food based on nucleic acid hydrogel;
图14为不同放置时间水凝胶的稳定性图;Fig. 14 is the stability diagram of different placement time hydrogel;
图15为与其他真菌毒素的特异性图;Figure 15 is a specificity map with other mycotoxins;
图16为加标回收图。Figure 16 is a graph of spike recovery.
具体实施方式Detailed ways
下面结合实施例对本申请进行进一步的介绍。The present application will be further introduced below with reference to the embodiments.
为了更清楚地说明本发明实施例或现有技术中的技术方案,在下述说明中,不同的“一实施例”或“实施例”指的不一定是同一实施例。不同实施例之间可以替换或者合并组合,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些实施例获得其他的实施方式。In order to describe the embodiments of the present invention or the technical solutions in the prior art more clearly, in the following description, different "an embodiment" or "embodiments" do not necessarily refer to the same embodiment. Different embodiments can be replaced or combined, and for those skilled in the art, other implementations can also be obtained according to these embodiments without creative efforts.
结合图1,一种基于核酸水凝胶快速检测食品中T-2毒素的方法,包括如下步骤:With reference to Figure 1, a method for rapid detection of T-2 toxin in food based on nucleic acid hydrogel includes the following steps:
构建以T-2毒素适体为linker交联剂的核酸水凝胶,所述的核酸水凝胶中均匀包埋着辣根过氧化物酶;Constructing a nucleic acid hydrogel using T-2 toxin aptamer as a linker cross-linking agent, wherein horseradish peroxidase is evenly embedded in the nucleic acid hydrogel;
向所述的核酸水凝胶中加入加入待测样,待测样中T-2毒素浓度为0.01ng mL-1-10000ng mL-1,所述的T-2毒素适体与T-2毒素结合,凝胶破裂,释放出辣根过氧化物酶;A sample to be tested is added to the nucleic acid hydrogel, the concentration of T-2 toxin in the sample to be tested is 0.01ng mL -1 -10000ng mL -1 , the T-2 toxin aptamer and T-2 toxin bind, the gel breaks, releasing horseradish peroxidase;
在一定时间内,辣根过氧化物酶催化过氧化氢和碘化钾反应生成碘单质刻蚀金纳米棒,根据金纳米棒在紫外分光光度计下呈现的吸收峰计算T-2毒素的含量。In a certain period of time, horseradish peroxidase catalyzes the reaction of hydrogen peroxide and potassium iodide to generate iodine to etch gold nanorods, and the content of T-2 toxin is calculated according to the absorption peak of gold nanorods under UV spectrophotometer.
在本发明的一些实施例中,所述的构建以T-2毒素适体为交联剂的核酸水凝胶包括如下步骤:In some embodiments of the present invention, the described construction of the nucleic acid hydrogel using T-2 toxin aptamer as a cross-linking agent comprises the following steps:
修饰有丙烯酰胺的互补链A100μM和互补链B100μM分别加入终浓度为4wt%丙烯酰胺,随后在35-40℃抽排空气10-15min,除去氧气;100 μM of the complementary chain A and 100 μM of the complementary chain B modified with acrylamide were respectively added with a final concentration of 4wt% acrylamide, and then the air was evacuated at 35-40 ° C for 10-15 min to remove oxygen;
加入终浓度为1.4%新鲜配制的过硫酸铵和终浓度为2.8%新鲜配制的四甲基乙二胺;在35-40℃抽排空气,反应10-15min,可得到髙分子互补链A和互补链B;Add freshly prepared ammonium persulfate with a final concentration of 1.4% and freshly prepared tetramethylethylenediamine with a final concentration of 2.8%; extract the air at 35-40°C, and react for 10-15min to obtain high molecular complementary chains A and complementary strand B;
将髙分子互补链A和互补链B混匀后在60-65℃下孵育5-10min,重复加热两次确保试剂完全混匀。随后加入不同浓度的交联剂(30、35、40、45μM)及辣根过氧化物酶,在60-65℃下孵育5-10min,重复加热3次确保试剂混匀,再冷却至室温形成核酸水凝胶。Mix the high molecular complementary strand A and the complementary strand B, incubate at 60-65 °C for 5-10 min, and repeat the heating twice to ensure that the reagents are completely mixed. Then add different concentrations of cross-linking agent (30, 35, 40, 45 μM) and horseradish peroxidase, incubate at 60-65 °C for 5-10 min, repeat heating 3 times to ensure that the reagents are mixed, and then cool to room temperature to form Nucleic acid hydrogels.
用磷酸缓冲溶液洗涤胶平面,除去胶表面多余的辣根过氧化物酶。Wash the surface of the gel with phosphate buffered solution to remove excess horseradish peroxidase on the surface of the gel.
在本发明的一些实施例中,所述的金纳米棒由如下方法制备而得:In some embodiments of the present invention, the gold nanorods are prepared by the following methods:
制备金种子:在0.5-1.0mL 0.5mM四氯金酸溶液中加入0.5-1.0mL 0.2M十六烷基三甲基溴化铵溶液;振荡混匀后,立即加入0.1-0.2mL 6mM新鲜配制的硼氢化钠溶液;剧烈振荡2-5min,种子溶液由黄色变成茶色,室温静置30-45min后即可得到金种子,常温保存,备用;To prepare gold seeds: add 0.5-1.0mL of 0.2M cetyltrimethylammonium bromide solution to 0.5-1.0mL of 0.5mM tetrachloroauric acid solution; after shaking and mixing, immediately add 0.1-0.2mL of 6mM freshly prepared The sodium borohydride solution; Vigorously shake for 2-5min, the seed solution changes from yellow to brown, and then stand at room temperature for 30-45min to obtain gold seeds, store at room temperature for later use;
制备生长液:称取0.9-1.1g十六烷基三甲基溴化铵及0.11-0.13g 5-溴水杨酸于250mL圆底烧瓶中,用25-30mL温水(50-70℃)溶解;随后加入1.2-1.5mL 4.0mM硝酸银溶液。得到的溶液放入30-37℃的水浴锅中下静置15-20min后,加入25mL 1.0mM四氯金酸溶液,搅拌15-20min;最后加入0.2mL 0.064-0.072M抗坏血酸,混匀30-60s直至溶液变成无色,即可得到生长液;Preparation of growth solution: Weigh 0.9-1.1g cetyltrimethylammonium bromide and 0.11-0.13g 5-bromosalicylic acid in a 250mL round-bottom flask, dissolve with 25-30mL warm water (50-70℃) ; 1.2-1.5 mL of 4.0 mM silver nitrate solution was then added. The obtained solution was placed in a water bath at 30-37°C and allowed to stand for 15-20min, then 25mL of 1.0mM tetrachloroauric acid solution was added and stirred for 15-20min; finally, 0.2mL of 0.064-0.072M ascorbic acid was added and mixed for 30- 60s until the solution becomes colorless, the growth solution can be obtained;
金纳米棒的生长:在上述得到的生长液中加入80-85μL制得的种子液,混匀后置于30-37℃水浴锅中,静置12-14h,得到所需的金纳米棒。最后,得到的金纳米棒用0.05M十六烷基三甲基溴化铵离心重悬3遍除去生长液。Growth of gold nanorods: Add 80-85 μL of the obtained seed solution to the growth solution obtained above, mix well, place in a water bath at 30-37°C, and let stand for 12-14 hours to obtain the desired gold nanorods. Finally, the obtained gold nanorods were centrifuged and resuspended three times with 0.05M cetyltrimethylammonium bromide to remove the growth solution.
在本发明的一些实施例中,所述的髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为110:100:45时,核酸水凝胶响应时间为15min。In some embodiments of the present invention, when the amount ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 110:100:45, the response time of the nucleic acid hydrogel is 15min.
在本发明的一些实施例中,所述的碘化钾的浓度为0.10M。In some embodiments of the present invention, the concentration of the potassium iodide is 0.10M.
在本发明的一些实施例中,所述的过氧化氢的浓度为0.075M。In some embodiments of the present invention, the concentration of the hydrogen peroxide is 0.075M.
在本发明的一些实施例中,根据金纳米棒在紫外分光光度计下呈现的吸收峰计算T-2毒素的含量包括步骤:建立标准曲线:在上述水凝胶中加入10μL不同浓度的T-2毒素标准样品,室温下静置15min后,移出上清液于2mL 0.05mg/mL金纳米棒,5mL 0.10M碘化钾20mL 0.075M过氧化氢中,室温下静置3min后,进行紫外光谱扫描。In some embodiments of the present invention, calculating the content of T-2 toxin according to the absorption peak presented by gold nanorods under an ultraviolet spectrophotometer includes the steps of: establishing a standard curve: adding 10 μL of T-2 toxin in different concentrations to the
金纳米棒的制备Preparation of gold nanorods
制备金种子。在0.5-1.0mL 0.5mM四氯金酸溶液中加入0.5-1.0mL 0.2M十六烷基三甲基溴化铵溶液。振荡混匀后,立即加入0.1-0.2mL 6mM新鲜配制的硼氢化钠溶液。剧烈振荡2-5min,种子溶液由黄色变成茶色,室温静置30-45min后即可得到金种子,常温保存,备用。Prepare golden seeds. Add 0.5-1.0 mL of 0.2 M cetyltrimethylammonium bromide solution to 0.5-1.0 mL of 0.5 mM tetrachloroauric acid solution. Immediately after mixing by shaking, add 0.1-0.2 mL of 6 mM freshly prepared sodium borohydride solution. Vigorously shake for 2-5min, the seed solution changes from yellow to brown, and after standing at room temperature for 30-45min, gold seeds can be obtained, which can be stored at room temperature for later use.
制备生长液。称取0.9-1.1g十六烷基三甲基溴化铵及0.11-0.13g 5-溴水杨酸于250mL圆底烧瓶中,用25-30mL温水(50-70℃)溶解。随后加入1.2-1.5mL 4.0mM硝酸银溶液。得到的溶液放入30-37℃的水浴锅中下静置15-20min后,加入25mL 1.0mM四氯金酸溶液,搅拌15-20min。最后加入0.2mL 0.064-0.072M抗坏血酸,混匀30-60s直至溶液变成无色,即可得到生长液。Prepare growth fluid. Weigh 0.9-1.1 g of cetyltrimethylammonium bromide and 0.11-0.13 g of 5-bromosalicylic acid in a 250-mL round-bottom flask, and dissolve with 25-30 mL of warm water (50-70° C.). 1.2-1.5 mL of 4.0 mM silver nitrate solution was then added. The obtained solution was placed in a water bath at 30-37°C and allowed to stand for 15-20min, then 25mL of 1.0mM tetrachloroauric acid solution was added and stirred for 15-20min. Finally, 0.2mL of 0.064-0.072M ascorbic acid was added, and the solution was mixed for 30-60s until the solution became colorless, and the growth solution was obtained.
金纳米棒的生长。在上述得到的生长液中加入80-85μL制得的种子液,混匀后置于30-37℃水浴锅中,静置12-14h,得到所需的金纳米棒。最后,得到的金纳米棒用0.05M十六烷基三甲基溴化铵离心重悬3遍除去生长液,用于后续实验。Growth of gold nanorods. Add 80-85 μL of the prepared seed solution to the above-obtained growth solution, mix well, place in a 30-37° C. water bath, and let stand for 12-14 hours to obtain the desired gold nanorods. Finally, the obtained gold nanorods were centrifuged and resuspended 3 times with 0.05M cetyltrimethylammonium bromide to remove the growth solution and used for subsequent experiments.
金纳米棒刻蚀前TEM如图2所示,刻蚀后TEM如图3所示。分别对应的紫外吸收光谱图如图4所示。如图5所示,进行不可刻蚀性验证,在没有辣根过氧化物酶存在时一定时间内过氧化氢和碘化钾不会反应,无碘单质成,不会刻蚀金纳米棒产生峰位移。The TEM of the gold nanorods before etching is shown in Figure 2, and the TEM after etching is shown in Figure 3. The corresponding UV absorption spectra are shown in Figure 4. As shown in Figure 5, the non-etchability verification is carried out. In the absence of horseradish peroxidase, hydrogen peroxide and potassium iodide will not react for a certain period of time, and without iodine, the gold nanorods will not be etched to produce peak shifts. .
核酸水凝胶的制备Preparation of Nucleic Acid Hydrogels
修饰有丙烯酰胺的互补链A和互补链B(各100μM)分别加入终浓度为4wt%丙烯酰胺,随后在35-40℃抽排空气10-15min,除去氧气。Acrylamide-modified complementary chain A and complementary chain B (100 μM each) were respectively added with a final concentration of 4 wt% acrylamide, and then air was evacuated at 35-40° C. for 10-15 min to remove oxygen.
加入终浓度为1.4%新鲜配制的过硫酸铵和终浓度为2.8%新鲜配制的四甲基乙二胺。在35-40℃抽排空气,反应10-15min,可得到髙分子互补链A和互补链B。Freshly prepared ammonium persulfate at a final concentration of 1.4% and freshly prepared tetramethylethylenediamine at a final concentration of 2.8% were added. At 35-40 ℃, the air was exhausted, and the reaction was carried out for 10-15 minutes to obtain the complementary chain A and the complementary chain B of the high molecular weight.
将髙分子互补链A和互补链B混匀后在60-65℃下孵育5-10min,重复加热两次确保试剂完全混匀。随后加入不同浓度的交联剂(30、35、40、45μM)及辣根过氧化物酶,在60-65℃下孵育5-10min,重复加热3次确保试剂混匀,再冷却至室温形成核酸水凝胶。Mix the high molecular complementary strand A and the complementary strand B, incubate at 60-65 °C for 5-10 min, and repeat the heating twice to ensure that the reagents are completely mixed. Then add different concentrations of cross-linking agent (30, 35, 40, 45 μM) and horseradish peroxidase, incubate at 60-65 °C for 5-10 min, repeat heating 3 times to ensure that the reagents are mixed, and then cool to room temperature to form Nucleic acid hydrogels.
用磷酸缓冲溶液洗涤胶平面,除去胶表面多余的辣根过氧化氢酶。Wash the surface of the gel with phosphate buffered solution to remove excess horseradish catalase on the surface of the gel.
水凝胶成胶条件的优化Optimization of hydrogel forming conditions
优化了髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比,比例范围在100:100:40-100:100:55之间。如图6所示,如图6a所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:40时,20min后实验组上清310nm处吸光值较大,说明水凝胶瓦解充分;然而,对照组在静置20min后上清310nm吸光值随时间的增加而明显增大了,说明当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:40时,水凝胶不稳定,即使在无靶标存在时,自身也会瓦解。如图6b所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:45时,随着时间的增加,实验组上清中辣根过氧化物酶的吸收值逐渐増加,且20min后吸收值几乎保持不变,说明20min后水凝胶基本瓦解充分;同时,对照组上清液的310nm吸收值在20min内基本保持不变,说明此条件下水凝胶非常稳定。如图6c和6d所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:50/55时,虽然40min内两组对照组上清液的310nm吸收值几乎保持不变,水凝胶很稳定,然而静置40min后,其对应的实验组上清310nm吸收值都较小,说明该条件下,水凝胶太稳定了,1μM毒素只能使水凝胶发生微弱的瓦解,响应效果不佳。综上所述,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:45时,核酸水凝胶对毒素的响应最佳。The ratio of the amount of the high molecular complementary chain A, the high molecular complementary chain B and the cross-linking agent was optimized, and the ratio ranged from 100:100:40-100:100:55. As shown in Figure 6, as shown in Figure 6a, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B and the cross-linking agent is 100:100:40, the supernatant of the experimental group after 20 minutes The absorbance value at 310nm was larger, indicating that the hydrogel was fully disintegrated; however, the absorbance value at 310nm of the supernatant in the control group increased significantly with the increase of time after standing for 20min, indicating that when the high molecular complementary chain A, high molecular complementary chain B. When the ratio of the three substances of the crosslinking agent is 100:100:40, the hydrogel is unstable, and even in the absence of the target, it will disintegrate itself. As shown in Figure 6b, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 100:100:45, with the increase of time, the supernatant in the experimental group is hot and spicy. The absorption value of root peroxidase gradually increased, and the absorption value remained almost unchanged after 20 min, indicating that the hydrogel was basically disintegrated after 20 min; at the same time, the 310 nm absorption value of the supernatant of the control group remained basically unchanged within 20 min, It shows that the hydrogel is very stable under this condition. As shown in Figures 6c and 6d, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 100:100:50/55, although the two groups of control groups were in the control group within 40min The absorption value of the supernatant at 310 nm remained almost unchanged, and the hydrogel was very stable. However, after standing for 40 minutes, the absorption value of the supernatant at 310 nm in the corresponding experimental group was smaller, indicating that the hydrogel was too stable under this condition. The toxin can only weakly disintegrate the hydrogel and respond poorly. To sum up, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B and the cross-linking agent is 100:100:45, the nucleic acid hydrogel has the best response to the toxin.
水凝胶水解时间的优化Optimization of hydrogel hydrolysis time
优化了髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比,比例范围在90:100:45-120:100:45之间。如图7所示,如图7a所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为90:100:45时,10min后对照组上清液的310nm吸收值几乎保持不变,水凝胶很稳定,然而静置10min后,其对应的实验组上清310nm吸收值较小,说明该条件下,水凝胶太稳定了,1μM毒素只能使水凝胶发生微弱的瓦解,响应效果不佳。如图7b所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为100:100:45时,随着时间的增加,实验组上清中辣根过氧化物酶的吸收值逐渐増加,且20min后吸收值几乎保持不变,说明20min后水凝胶基本瓦解充分;同时,对照组上清液的310nm吸收值在20min内基本保持不变,说明此条件下水凝胶非常稳定。但对比图7c,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为110:100:45时,现象与图7b基本相同,但在15min时实验组上清中辣根过氧化物酶的吸收值几乎保持不变,说明15min后水凝胶已基本瓦解充分。时间更短。如图7d所示,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为120:100:45时,15min后实验组上清310nm处吸光值较大,说明水凝胶瓦解充分;然而,对照组在静置15min后上清310nm吸光值随时间的增加而明显增大了,说明当linker浓度为40μM时,水凝胶不稳定,即使在无靶标存在时,自身也会瓦解。综上所述,当髙分子互补链A、髙分子互补链B、交联剂三者的物质的量之比为110:100:45时,核酸水凝胶对毒素的响应最佳,响应时间为15min。The ratio of the amount of the high molecular complementary chain A, the high molecular complementary chain B and the cross-linking agent was optimized, and the ratio ranged from 90:100:45-120:100:45. As shown in Figure 7, as shown in Figure 7a, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 90:100:45, the supernatant of the control group after 10 minutes The absorption value at 310 nm of the liquid remained almost unchanged, and the hydrogel was very stable. However, after standing for 10 min, the absorption value at 310 nm of the supernatant in the corresponding experimental group was smaller, indicating that under this condition, the hydrogel was too stable, and 1 μM toxin only The hydrogel can be weakly disintegrated, and the response effect is not good. As shown in Figure 7b, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 100:100:45, with the increase of time, the supernatant in the experimental group is hot and spicy. The absorption value of root peroxidase gradually increased, and the absorption value remained almost unchanged after 20 min, indicating that the hydrogel was basically disintegrated after 20 min; at the same time, the 310 nm absorption value of the supernatant of the control group remained basically unchanged within 20 min, It shows that the hydrogel is very stable under this condition. But compared to Figure 7c, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 110:100:45, the phenomenon is basically the same as Figure 7b, but at 15 minutes the experimental group The absorption value of horseradish peroxidase in the supernatant remained almost unchanged, indicating that the hydrogel had basically collapsed completely after 15 minutes. less time. As shown in Figure 7d, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 120:100:45, the absorbance at 310 nm of the supernatant in the experimental group is larger after 15 minutes. , indicating that the hydrogel was fully disintegrated; however, the absorbance at 310 nm of the supernatant in the control group increased significantly with time after standing for 15 min, indicating that when the linker concentration was 40 μM, the hydrogel was unstable, even in the absence of target When it exists, it also disintegrates itself. To sum up, when the ratio of the substances of the high molecular complementary chain A, the high molecular complementary chain B, and the cross-linking agent is 110:100:45, the nucleic acid hydrogel has the best response to the toxin, and the response time is the best. for 15min.
碘化钾浓度的优化Optimization of potassium iodide concentration
优化了5个浓度,分别为0.08M、0.09M、0.10M、0.11M、0.12M,如图8所示,当碘化钾浓度在0.08M-0.10M时,其峰位移逐渐增加,当碘化钾浓度在0.10M时,其峰位移达到最大值,故最佳浓度为0.10M。Five concentrations were optimized, 0.08M, 0.09M, 0.10M, 0.11M, and 0.12M, respectively. As shown in Figure 8, when the potassium iodide concentration was between 0.08M and 0.10M, the peak shift gradually increased. At 0.10M, its peak shift reaches the maximum value, so the optimal concentration is 0.10M.
过氧化氢浓度的优化Optimization of hydrogen peroxide concentration
优化了5个浓度,分别为0.065M、0.070M、0.075M、0.080M、0.085M,如图9所示,当过氧化氢浓度在0.065M-0.075M时,其峰位移逐渐增加,当过氧化氢浓度在0.075M时,其峰位移达到最大值,故最佳浓度为0.075M。Five concentrations were optimized, which were 0.065M, 0.070M, 0.075M, 0.080M, and 0.085M, respectively. As shown in Figure 9, when the concentration of hydrogen peroxide was between 0.065M and 0.075M, its peak shift gradually increased. When the concentration of hydrogen oxide is 0.075M, its peak shift reaches the maximum value, so the optimal concentration is 0.075M.
标准曲线的建立Establishment of standard curve
在上述水凝胶中加入10μL不同浓度的T-2毒素标准样品,室温下静置15min后,移出上清液于2mL 0.05mg/mL金纳米棒,5mL 0.10M碘化钾,20mL 0.075M过氧化氢中,室温下静置3min后,进行紫外光谱扫描。其中图10为未瓦解水凝胶TEM图,图11为完全瓦解水凝胶TEM图。Add 10 μL of T-2 toxin standard samples of different concentrations to the above hydrogel, and after standing at room temperature for 15 min, remove the supernatant and add 2 mL of 0.05 mg/mL gold nanorods, 5 mL of 0.10 M potassium iodide, and 20 mL of 0.075 M hydrogen peroxide After standing at room temperature for 3 min, the UV spectrum was scanned. 10 is the TEM image of the undisintegrated hydrogel, and FIG. 11 is the TEM image of the completely disintegrated hydrogel.
在以上实验条件的情况下,使用一系列稀释浓度的T-2毒素标准样品绘制标准曲线。如图12所示,峰位移随着T-2毒素浓度的增加而增大,该趋势可以做如下解释:当不同浓度的T-2毒素加入水凝胶中时,水凝胶中的交联剂会与毒素特异性结合,使水凝胶破裂,变为溶液,释放出水凝胶中包埋的辣根过氧化物酶,释放辣根过氧化物酶的量与毒素含量成正比。将水凝胶体系中的液体移入金纳米棒中,辣根过氧化物酶催化过氧化氢和碘化钾反应生成碘单质刻蚀金纳米棒,使金纳米棒呈现不同的颜色,并在紫外分光光度计下呈现不同位置的吸收峰,金纳米棒的峰位移与T-2毒素浓度成正比。如图13所示,以T-2毒素浓度为横坐标,金纳米棒的峰位移为纵坐标,得到的标准曲线为Y=32.3129lgX+54.0285,R2=0.9991,T-2毒素浓度在0.01ng/mL~10000ng/mL呈良好的线性关系,最低检出限为0.87pgmL-1。With the above experimental conditions, a standard curve was developed using a series of dilution concentrations of T-2 toxin standard samples. As shown in Figure 12, the peak shift increases with increasing T-2 toxin concentration, and this trend can be explained as follows: When different concentrations of T-2 toxin were added to the hydrogel, the cross-linking in the hydrogel The agent will specifically bind to the toxin, break the hydrogel, turn it into a solution, and release the horseradish peroxidase embedded in the hydrogel. The amount of horseradish peroxidase released is proportional to the toxin content. The liquid in the hydrogel system is moved into the gold nanorods, and horseradish peroxidase catalyzes the reaction of hydrogen peroxide and potassium iodide to generate iodine to etch the gold nanorods, so that the gold nanorods show different colors, and can be detected in ultraviolet spectrophotometry. There are absorption peaks at different positions under the meter, and the peak shift of gold nanorods is proportional to the concentration of T-2 toxin. As shown in Figure 13, taking the T-2 toxin concentration as the abscissa and the peak shift of the gold nanorods as the ordinate, the obtained standard curve is Y=32.3129lgX+54.0285, R 2 =0.9991, and the T-2 toxin concentration is 0.01 ng/mL~10000ng/mL showed a good linear relationship, and the minimum detection limit was 0.87pgmL -1 .
检测方法的稳定性Stability of the detection method
为了评价本发明方法的稳定性,分别取制作30天、20天、10天、1天的水凝胶,加入高中低不同浓度的T-2毒素标准样品。如图14所示,不同储存时间的水凝胶检测时得到的峰位移差别不大。说明本方法制得的水凝胶稳定性良好。In order to evaluate the stability of the method of the present invention, hydrogels prepared for 30 days, 20 days, 10 days and 1 day were respectively taken, and standard samples of T-2 toxin with different concentrations of high, medium and low were added. As shown in Figure 14, the peak shifts obtained when the hydrogels were tested with different storage times were not significantly different. It shows that the hydrogel prepared by this method has good stability.
检测方法的特异性specificity of the detection method
为了评价本发明方法的特异性,选取了和T-2毒素都属于真菌毒素的干扰物赭曲霉毒素(OTA)、伏马镰刀毒素(FB1)、黄曲霉毒素B1(AFB1)、呕吐毒素(DON)、玉米赤霉烯酮毒素(ZEN),从理论上讲,该方法的特异性主要取决于T-2毒素和T-2毒素适体的特异性结合,如果T-2毒素适体和其它真菌毒素结合,则会产生假阳性信号。如图15所示,加入10ng/mL不同毒素后,T-2毒素的峰位移最为明显。说明本方法制得的水凝胶特异性良好。In order to evaluate the specificity of the method of the present invention, the interfering substances ochratoxin (OTA), fumonisin (FB1), aflatoxin B1 (AFB1), vomitoxin (DON), which are both mycotoxins and T-2 toxins, were selected. ), zearalenone toxin (ZEN), theoretically, the specificity of this method mainly depends on the specific binding of T-2 toxin and T-2 toxin aptamer, if T-2 toxin aptamer and other Binding of mycotoxins produces a false positive signal. As shown in Figure 15, the peak shift of T-2 toxin was the most obvious after adding 10 ng/mL of different toxins. It shows that the hydrogel prepared by this method has good specificity.
实际样品的检测Detection of actual samples
采用加标回收实验。选取玉米、大豆、咖啡作为实际样品。称取1-1.5g玉米粉、大豆粉、咖啡粉加入到5mL离心管中,之后加入2-3mL浓度为100ng/mL的T-2毒素溶液(用甲醇:PBS=7:3稀释),涡旋震荡5-7min后10000rpm/min离心15-20min,取上清液,0.45μm过滤膜进行过滤,然后稀释为50ng/mL、1ng/mL、0.1ng/mL(用甲醇:PBS=7:3稀释)进行加标回收实验。在检测范围内设置高中低不同浓度(50ng/mL、1ng/mL、0.1ng/mL),每个浓度平行测定3次,计算加标回收率,如图16所示,本发明的加标回收率在93.72%~103.07%,其中相对标准偏差(relative standard deviation,RSD)在3.87%~7.07%之间。说明本发明方法准确可靠。A spiked recovery experiment was used. Select corn, soybean, and coffee as actual samples. Weigh 1-1.5g corn flour, soybean flour and coffee powder into a 5mL centrifuge tube, then add 2-3mL T-2 toxin solution with a concentration of 100ng/mL (diluted with methanol:PBS=7:3), vortex Centrifuge at 10000rpm/min for 15-20min after vortexing for 5-7min, take the supernatant, filter with 0.45μm filter membrane, and then dilute to 50ng/mL, 1ng/mL, 0.1ng/mL (with methanol:PBS=7:3 dilution) for spike recovery experiments. Different concentrations (50ng/mL, 1ng/mL, 0.1ng/mL) were set in the detection range, and each concentration was measured in parallel for 3 times, and the recovery rate of standard addition was calculated. As shown in Figure 16, the standard addition recovery rate of the present invention was The rate was between 93.72% and 103.07%, and the relative standard deviation (RSD) was between 3.87% and 7.07%. It shows that the method of the present invention is accurate and reliable.
应当说明的是,上述实施例均可根据需要自由组合。以上介绍仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。It should be noted that the above embodiments can be freely combined as required. The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910919297.4A CN110736829A (en) | 2019-09-26 | 2019-09-26 | Rapid detection of T-2 toxin in food based on nucleic acid hydrogel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910919297.4A CN110736829A (en) | 2019-09-26 | 2019-09-26 | Rapid detection of T-2 toxin in food based on nucleic acid hydrogel |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110736829A true CN110736829A (en) | 2020-01-31 |
Family
ID=69269572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910919297.4A Pending CN110736829A (en) | 2019-09-26 | 2019-09-26 | Rapid detection of T-2 toxin in food based on nucleic acid hydrogel |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110736829A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113916872A (en) * | 2021-09-17 | 2022-01-11 | 河南工业大学 | A colorimetric method for the detection of aflatoxin B1 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104249158A (en) * | 2013-06-26 | 2014-12-31 | 梁萍 | Growth solution for largely preparing gold nanorods |
CN104293793A (en) * | 2014-07-24 | 2015-01-21 | 江南大学 | Oligonucleotide aptamer specifically recognizing T-2 toxin |
CN105784995A (en) * | 2016-02-25 | 2016-07-20 | 厦门大学 | Method for DNA intelligent hydrogel visual quantitative and/or semiquantitative detection of aflatoxin B1 |
-
2019
- 2019-09-26 CN CN201910919297.4A patent/CN110736829A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104249158A (en) * | 2013-06-26 | 2014-12-31 | 梁萍 | Growth solution for largely preparing gold nanorods |
CN104293793A (en) * | 2014-07-24 | 2015-01-21 | 江南大学 | Oligonucleotide aptamer specifically recognizing T-2 toxin |
CN105784995A (en) * | 2016-02-25 | 2016-07-20 | 厦门大学 | Method for DNA intelligent hydrogel visual quantitative and/or semiquantitative detection of aflatoxin B1 |
Non-Patent Citations (4)
Title |
---|
HONGHONG RAO ET AL.: "Gold nanorod etching-based multicolorimetric sensors: strategies and applications", 《JOURNAL OF MATERIALS CHEMISTRY C》 * |
李荣超: "纳米材料在酶联免疫分析中的应用研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
胥彦琪: "基于HRP催化诱导金纳米棒形貌改变的碘离子检测研究", 《化学研究与应用》 * |
魏晓峰: "功能化DNA生物传感器的研究和应用", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113916872A (en) * | 2021-09-17 | 2022-01-11 | 河南工业大学 | A colorimetric method for the detection of aflatoxin B1 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Soleas et al. | Assay of ochratoxin A in wine and beer by high-pressure liquid chromatography photodiode array and gas chromatography mass selective detection | |
Wang et al. | Rapid determination of fumonisin B1 in food samples by enzyme-linked immunosorbent assay and colloidal gold immunoassay | |
Magliulo et al. | Development and validation of an ultrasensitive chemiluminescent enzyme immunoassay for aflatoxin M1 in milk | |
Xiong et al. | Colorimetric ELISA based on glucose oxidase-regulated the color of acid–base indicator for sensitive detection of aflatoxin B1 in corn samples | |
Pennacchio et al. | A surface plasmon resonance based biochip for the detection of patulin toxin | |
CN102539425B (en) | Raid detection method for heavy metal lead in tea leaves | |
Dai et al. | Colorimetric ELISA based on urease catalysis curcumin as a ratiometric indicator for the sensitive determination of aflatoxin B1 in grain products | |
CN110330974B (en) | Preparation and application of zearalenone ratiometric fluorescent probe | |
Mirón-Mérida et al. | Aptamer-based detection of fumonisin B1: A critical review | |
CN110015992A (en) | A kind of fluorescent probe for sulfur dioxide/sulfite (hydrogen) salt detection and preparation method and application thereof | |
CN106914227A (en) | The preparation method and method of evaluating performance of anabasine pesticide fluorescence molecule imprinted polymer microballoon | |
CN110736829A (en) | Rapid detection of T-2 toxin in food based on nucleic acid hydrogel | |
CN111795964A (en) | A method for quantitatively detecting octanoyl hydroxamic acid in cosmetics based on spectrophotometry | |
Ockun et al. | Comparative evaluation of phenolic profile and antioxidant activity of new sweet cherry (Prunus avium L.) genotypes in Turkey | |
Nitao et al. | Rapid quantification of proanthocyanidins (condensed tannins) with a continuous flow analyzer | |
Burkin et al. | Enzyme immunassay of alternariol for the assessment of risk of agricultural products contamination | |
CN115267194A (en) | An indirect competitive enzyme-linked immunosorbent assay for the detection of aflatoxin B1 | |
Yuan et al. | An immediate and antibody protected carboxyl quantum dot immunochromatographic analysis hierarchical signal amplification test strip based on biotin-streptavidin system for the detection of aflatoxin B1 in peanuts | |
CN101598716A (en) | A kind of gossypol rapid detection test strip and its preparation method and application | |
Zvereva et al. | Highly sensitive immunochromatographic assay for qualitative and quantitative control of beta-agonist ractopamine in foods | |
CN112816701B (en) | Method for rapidly detecting ricin by colloid Jin Celiu chromatography and colloid Jin Celiu chromatography kit | |
CN105300945A (en) | Fluorescence quenching method for quantitative analysis of chitosan | |
CN115097115A (en) | Preparation method and application of PAMAM sensitization-based ochratoxin A aptamer test strip | |
CN108760695A (en) | A method of the phosphorescence probe based on PRET quantitatively detects fibrin ferment | |
CN115948406A (en) | Ractopamine detection method based on bifunctional chemical nanoenzyme-coated DNA hydrogel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200131 |